Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma

Published:2016 Issue:1 Volume:22 Page:262
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Song Pei-Pei

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference156 articles.

1. World Health Organization. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Accessed March 2, 2015. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.

2. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127:S35-S50.

3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.

4. EASL Clinical Practice Guidelines: Management of chronic hepatitis B

5. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study;World Journal of Gastroenterology;2024-05-07

2. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation;Journal of Cancer Research and Clinical Oncology;2024-05-07

3. Bioinformatics and machine learning driven key genes screening for hepatocellular carcinoma;Biochemistry and Biophysics Reports;2024-03

4. Clinical utility of biomarkers of hepatocellular carcinoma;Bratislava Medical Journal;2024

5. The preliminary data of gene expressions and bioinformatics analysis of miR-146b-5p and miR-4510 in the Turkish population in HBV-related hepatocellular carcinoma;Hepatology Forum;2024